{"id":"nasonex","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute tuberculosis","Adrenal cortical hypofunction","Asthenia","Atrophoderma","Bacterial infectious disease","Bilateral cataracts","Chronic myocardial ischemia","Conduction disorder of the heart","Congenital long QT syndrome","Denuded skin","Diabetes mellitus","Disease caused by parasite","Disease of liver","Epistaxis","Exacerbation of asthma","Fissure in skin","Glaucoma","Hypertensive disorder","Hypokalemia","Hypopituitarism","Immunosuppression","Inactive tuberculosis","Measles","Mycosis","Nasal Candidiasis","Nasal Septal Ulcers","Nasal Trauma","Ocular hypertension","Operation on nose","Ophthalmic herpes simplex","Osteopenia","Osteoporosis","Perforation of nasal septum","Peripheral vascular disease","Prolonged QT interval","Seizure disorder","Skin irritation","Skin ulcer","Telangiectasia disorder","Thyrotoxicosis","Uncontrolled Bacterial Infections","Untreated Fungal Infection","Varicella","Varicella-zoster virus infection"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL1161","moleculeType":"Small molecule","molecularWeight":"521.44"},"aliases":["Mometasone Furoate Aqueous Nasal Spray","Mometasone furoate (generic name)"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Nasonex","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:50:52.590095+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:50:58.869375+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Nasonex","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:50:59.211040+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Glucocorticoid receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:51:00.268376+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1161/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:50:59.921228+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"13696a8b-366a-4a5e-adea-d5b7bff9e46f","title":"NASONEX (MOMETASONE FUROATE) SPRAY, METERED [L. PERRIGO COMPANY]"},"ecosystem":[],"mechanism":{"target":"Multidrug resistance protein 1, Glucocorticoid receptor, Progesterone receptor"},"_scrapedAt":"2026-03-27T23:56:40.638Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:51:01.476322+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Allergic Rhinitis Prevention","diseaseId":"allergic-rhinitis-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic asthma","diseaseId":"allergic-asthma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic rhinitis","diseaseId":"allergic-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Asthma","diseaseId":"asthma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Asthma management","diseaseId":"asthma-management","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Atopic dermatitis","diseaseId":"atopic-dermatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic Non-Allergic Rhinitis","diseaseId":"chronic-non-allergic-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Contact dermatitis","diseaseId":"contact-dermatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Discoid lupus erythematosus","diseaseId":"discoid-lupus-erythematosus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Eruption of skin","diseaseId":"eruption-of-skin","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Granuloma annulare","diseaseId":"granuloma-annulare","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Lichen simplex chronicus","diseaseId":"lichen-simplex-chronicus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Non-allergic asthma","diseaseId":"non-allergic-asthma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Plaque psoriasis","diseaseId":"plaque-psoriasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Primary cutaneous T-cell lymphoma","diseaseId":"primary-cutaneous-t-cell-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pruritus ani","diseaseId":"pruritus-ani","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pruritus of genital organs","diseaseId":"pruritus-of-genital-organs","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Scalp psoriasis","diseaseId":"scalp-psoriasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Seborrheic dermatitis","diseaseId":"seborrheic-dermatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06164951","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia","status":"COMPLETED","sponsor":"QED Therapeutics, a BridgeBio company","startDate":"2023-11-10","conditions":"Achondroplasia","enrollment":114},{"nctId":"NCT04127578","phase":"PHASE1, PHASE2","title":"Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Prevail Therapeutics","startDate":"2020-01-03","conditions":"Parkinson Disease","enrollment":32},{"nctId":"NCT05171816","phase":"PHASE3","title":"Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-24","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":110},{"nctId":"NCT06914908","phase":"PHASE2","title":"Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-05-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":64},{"nctId":"NCT06834347","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06834360","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-06","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06439381","phase":"PHASE2","title":"Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-07-16","conditions":"Chronic Rhinosinusitis","enrollment":120},{"nctId":"NCT05562466","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-05-11","conditions":"Asthma","enrollment":200},{"nctId":"NCT05295459","phase":"PHASE3","title":"Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)","status":"COMPLETED","sponsor":"Lyra Therapeutics","startDate":"2022-05-13","conditions":"Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)","enrollment":182},{"nctId":"NCT06454240","phase":"PHASE2","title":"A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-07-17","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":79},{"nctId":"NCT05776927","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-05-29","conditions":"Asthma","enrollment":304},{"nctId":"NCT03732820","phase":"PHASE3","title":"Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2018-10-31","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":895},{"nctId":"NCT04898764","phase":"PHASE4","title":"Research on Underlying Causes of Long-term Use of Nasal Decongestants and the Structured Withdrawal of the Decongestant","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2020-10-21","conditions":"Rhinitis Medicamentosa","enrollment":72},{"nctId":"NCT04851964","phase":"PHASE3","title":"Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-04-22","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":416},{"nctId":"NCT05925985","phase":"","title":"Propel Drug-Eluting Sinus Stent Family Open Cohort","status":"COMPLETED","sponsor":"Medtronic","startDate":"2023-06-01","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":215},{"nctId":"NCT02892344","phase":"PHASE3","title":"Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2017-01-16","conditions":"Mild Asthma","enrollment":802},{"nctId":"NCT07311759","phase":"PHASE3","title":"Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-08-17","conditions":"Chronic Paronychia","enrollment":21},{"nctId":"NCT06302439","phase":"","title":"PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency","status":"RECRUITING","sponsor":"Inozyme Pharma","startDate":"2024-07-25","conditions":"Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency, ATP-Binding Cassette Subfamily C Member 6 Deficiency","enrollment":1000},{"nctId":"NCT07286201","phase":"NA","title":"Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)","status":"NOT_YET_RECRUITING","sponsor":"Polyganics BV","startDate":"2026-01","conditions":"Chronic Rhinosinusitis (CRS), Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps","enrollment":110},{"nctId":"NCT05329129","phase":"","title":"OssDsign® Spine Registry Study (\"Propel\")","status":"RECRUITING","sponsor":"OssDsign","startDate":"2022-03-23","conditions":"Degenerative Disc Disease, Spinal Stenosis","enrollment":450},{"nctId":"NCT04715542","phase":"PHASE3","title":"Stibium Metallicum Praeparatum 6x Versus Placebo in the Prevention of Paclitaxel-induced Peripheral Neurotoxicity","status":"NOT_YET_RECRUITING","sponsor":"University of Bern","startDate":"2026-08","conditions":"Chemotherapy Induced Peripheral Neuropathy (CIPN)","enrollment":120},{"nctId":"NCT06565052","phase":"NA","title":"The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-12-15","conditions":"Rectal Cancer, Colorectal Cancer, Rectal Cancer Stage II","enrollment":40},{"nctId":"NCT06451640","phase":"PHASE2","title":"A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2024-07-04","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":59},{"nctId":"NCT07240376","phase":"NA","title":"Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2025-11-25","conditions":"Non-Allergic Rhinitis With Eosinophilia Syndrome","enrollment":90},{"nctId":"NCT06691113","phase":"PHASE2","title":"A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-12-16","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":60},{"nctId":"NCT06013241","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2023-10-30","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":288},{"nctId":"NCT05145010","phase":"PHASE2","title":"Extension Study of Infigratinib in Children With Achondroplasia (ACH)","status":"ENROLLING_BY_INVITATION","sponsor":"QED Therapeutics, a BridgeBio company","startDate":"2021-12-06","conditions":"Achondroplasia","enrollment":300},{"nctId":"NCT07052942","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care (Full Study)","status":"RECRUITING","sponsor":"DARTNet Institute","startDate":"2025-08-01","conditions":"Asthma, Asthma Attack, Asthma Exacerbations","enrollment":3200},{"nctId":"NCT04265651","phase":"PHASE2","title":"Study of Infigratinib in Children With Achondroplasia","status":"COMPLETED","sponsor":"QED Therapeutics, a BridgeBio company","startDate":"2020-03-10","conditions":"Achondroplasia","enrollment":84},{"nctId":"NCT05382494","phase":"PHASE4","title":"Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-12-05","conditions":"Sleep Disorder; Breathing-Related, Snoring, Obstructive Sleep Apnea of Child","enrollment":130},{"nctId":"NCT07174115","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","sponsor":"Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-08-18","conditions":"Chronic Sinusitis Without Nasal Polyps","enrollment":30},{"nctId":"NCT02951338","phase":"NA","title":"PROPEL Randomized Trial","status":"TERMINATED","sponsor":"Toronto Rehabilitation Institute","startDate":"2017-02-01","conditions":"Stroke","enrollment":57},{"nctId":"NCT02895100","phase":"PHASE2","title":"Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis","status":"TERMINATED","sponsor":"Protagonist Therapeutics, Inc.","startDate":"2016-12","conditions":"Ulcerative Colitis","enrollment":98},{"nctId":"NCT05217810","phase":"","title":"A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-05-09","conditions":"Asthma","enrollment":600},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT04480242","phase":"","title":"Asthma Research in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2017-07-26","conditions":"Persistent Asthma, Asthma in Children, Asthma Exacerbation","enrollment":525},{"nctId":"NCT06436534","phase":"NA","title":"Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-05-24","conditions":"Rhinitis, Allergic","enrollment":50},{"nctId":"NCT03705793","phase":"PHASE4","title":"Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-01-01","conditions":"Chronic Rhinosinusitis (Diagnosis), Allergic Rhinosinusitis, Chronic Eosinophilic Rhinosinusitis","enrollment":53},{"nctId":"NCT07016763","phase":"EARLY_PHASE1","title":"Combination of Oral Supplement With Fatty Acids, Vitamin B6, Perilla, and Liquorice With Nasal Steroids for the Treatment of Allergic Rhinitis","status":"COMPLETED","sponsor":"Isola Tiberina - Gemelli Isola Hospital, Rome, Italy","startDate":"2024-09-01","conditions":"Allergic Rhinitis","enrollment":400},{"nctId":"NCT07016113","phase":"PHASE2","title":"0.005% Latanoprost Gel for Nonsegmental Vitiligo","status":"NOT_YET_RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2025-07-01","conditions":"Vitiligo - Macular Depigmentation","enrollment":10},{"nctId":"NCT05756647","phase":"PHASE2","title":"Mandibular Advancement vs Home Treatment for Primary Snoring","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-11-07","conditions":"Snoring","enrollment":100},{"nctId":"NCT06636240","phase":"NA","title":"Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis","status":"RECRUITING","sponsor":"Taipei Medical University Shuang Ho Hospital","startDate":"2025-03-17","conditions":"Atopic Dermatitis (Eczema), Atopic Dermatitis, Probiotics","enrollment":120},{"nctId":"NCT06671561","phase":"","title":"Product Surveillance Registry; Ear, Nose and Throat - EXTEND Cohort","status":"WITHDRAWN","sponsor":"Medtronic","startDate":"2025-01-30","conditions":"Chronic Rhinosinusitis (CRS)","enrollment":""},{"nctId":"NCT05545072","phase":"PHASE3","title":"Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)","status":"TERMINATED","sponsor":"Emory University","startDate":"2023-10-26","conditions":"Allergic Fungal Rhinosinusitis","enrollment":5},{"nctId":"NCT05219968","phase":"PHASE3","title":"Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults","status":"COMPLETED","sponsor":"Lyra Therapeutics","startDate":"2022-01-27","conditions":"Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)","enrollment":196},{"nctId":"NCT06272370","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care","status":"COMPLETED","sponsor":"DARTNet Institute","startDate":"2024-02-01","conditions":"Asthma, Bronchial Diseases, Respiratory Tract Infections","enrollment":103},{"nctId":"NCT06036927","phase":"PHASE2","title":"A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-12-08","conditions":"Chronic Sinusitis, Nasal Polyps","enrollment":80},{"nctId":"NCT04035811","phase":"","title":"Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)","status":"ACTIVE_NOT_RECRUITING","sponsor":"QED Therapeutics, a BridgeBio company","startDate":"2019-08-12","conditions":"Achondroplasia","enrollment":271},{"nctId":"NCT06077019","phase":"NA","title":"Role of Lung Function for Exercise Capacity in Well-trained Individuals","status":"RECRUITING","sponsor":"Morten Hostrup, PhD","startDate":"2023-10-03","conditions":"Exercise Performance","enrollment":60},{"nctId":"NCT06733532","phase":"NA","title":"Comparison of the Beverage Hydration Index of Different Solutions","status":"COMPLETED","sponsor":"University of Memphis","startDate":"2024-11-21","conditions":"Hydration","enrollment":29},{"nctId":"NCT04009187","phase":"NA","title":"A Wheelchair Propulsion Training Program","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2018-03-27","conditions":"Spinal Cord Injuries, Multiple Sclerosis, Amputation","enrollment":20},{"nctId":"NCT06068270","phase":"NA","title":"Effect of MOPs During Orthodontic Movement in Periodontitis Patients","status":"RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2023-12-15","conditions":"Stage IV Periodontitis, Orthodontic Tooth Movement","enrollment":28},{"nctId":"NCT06118554","phase":"NA","title":"3D Printing to Improve Nasal Irrigation Outcome","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2021-11-01","conditions":"Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis Without Nasal Polyps","enrollment":200},{"nctId":"NCT03141424","phase":"PHASE4","title":"Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma","status":"COMPLETED","sponsor":"Hvidovre University Hospital","startDate":"2022-06-01","conditions":"Asthma","enrollment":20},{"nctId":"NCT00845481","phase":"PHASE2","title":"A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2009-01","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT05902325","phase":"PHASE4","title":"Identifying Predictors Of Response To Mepolizumab In CRSwNP","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-10-03","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":36},{"nctId":"NCT04596189","phase":"PHASE4","title":"Dupilumab for Prevention of Recurrence of CRSwNP After ESS","status":"COMPLETED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2021-05-25","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":30},{"nctId":"NCT03134755","phase":"","title":"Stress and Treatment Response in Puerto Rican Children With Asthma","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2018-05-15","conditions":"Asthma in Children","enrollment":249},{"nctId":"NCT06801353","phase":"PHASE4","title":"A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2025-02-01","conditions":"Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Biological Therapy, Biomarkers","enrollment":90},{"nctId":"NCT06780644","phase":"NA","title":"Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma","status":"NOT_YET_RECRUITING","sponsor":"Indonesia University","startDate":"2025-02-17","conditions":"Melasma","enrollment":56},{"nctId":"NCT06483477","phase":"NA","title":"Dermatitis During Adjuvant Irradiation for BREAst Cancer:","status":"RECRUITING","sponsor":"University Hospital Schleswig-Holstein","startDate":"2024-12-23","conditions":"Breast Cancer Female","enrollment":268},{"nctId":"NCT05274425","phase":"","title":"A 24-week rPMS Study in Real-world Setting for Enerzair","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-05-09","conditions":"Asthma","enrollment":600},{"nctId":"NCT05035654","phase":"PHASE2","title":"LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)","status":"COMPLETED","sponsor":"Lyra Therapeutics","startDate":"2021-11-23","conditions":"Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis)","enrollment":48},{"nctId":"NCT03930238","phase":"NA","title":"Increasing Steps Per Day in Rural Veterans","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2019-05-15","conditions":"Obesity, Overweight","enrollment":276},{"nctId":"NCT06642116","phase":"NA","title":"Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate","status":"NOT_YET_RECRUITING","sponsor":"Polyganics BV","startDate":"2024-11","conditions":"Rhinosinusitis Chronic, Wound Healing, Sinus Surgery","enrollment":20},{"nctId":"NCT00070707","phase":"PHASE4","title":"Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-03","conditions":"Rhinitis, Allergic, Seasonal, Asthma","enrollment":188},{"nctId":"NCT06573164","phase":"","title":"Allergic Rhinitis With/Without Asthma: Pre- and Post-Qipian Analysis","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-01-01","conditions":"Rhinitis, Allergic, Asthma","enrollment":60},{"nctId":"NCT00779740","phase":"PHASE3","title":"Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":102},{"nctId":"NCT00817050","phase":"PHASE4","title":"Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-12-01","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT00779545","phase":"PHASE2","title":"A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-04-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":455},{"nctId":"NCT00834119","phase":"PHASE4","title":"Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09-01","conditions":"Rhinitis, Allergic","enrollment":72},{"nctId":"NCT00835094","phase":"PHASE4","title":"A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-10-01","conditions":"Asthma","enrollment":216},{"nctId":"NCT00732368","phase":"PHASE3","title":"A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05-01","conditions":"Perennial Allergic Rhinitis","enrollment":98},{"nctId":"NCT00750750","phase":"PHASE2","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT00731185","phase":"PHASE3","title":"Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09-01","conditions":"Nasal Polyps","enrollment":162},{"nctId":"NCT00817817","phase":"PHASE3","title":"A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-10-01","conditions":"Asthma","enrollment":93},{"nctId":"NCT00763529","phase":"PHASE4","title":"Elocon vs Fluticasone in Localized Psoriasis (P03197)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01-01","conditions":"Psoriasis","enrollment":245},{"nctId":"NCT00783237","phase":"PHASE4","title":"Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Allergic Rhinitis","enrollment":340},{"nctId":"NCT00783458","phase":"PHASE4","title":"Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-12-01","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT00751075","phase":"PHASE3","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT03979209","phase":"PHASE1","title":"Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages.","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2019-01-14","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":16},{"nctId":"NCT01502371","phase":"PHASE2","title":"A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-01-25","conditions":"Asthma","enrollment":583},{"nctId":"NCT06448702","phase":"NA","title":"Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2024-07-03","conditions":"Atopic Dermatitis, Inflammatory Skin Disease","enrollment":40},{"nctId":"NCT01098071","phase":"PHASE4","title":"Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08-01","conditions":"Adenoids","enrollment":34},{"nctId":"NCT01135134","phase":"PHASE3","title":"Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06","conditions":"Rhinitis, Allergic, Perennial","enrollment":333},{"nctId":"NCT00687531","phase":"PHASE4","title":"Clinical Trial to Assess Efficacy, Safety, Treatment Adherence and Quality of Life Impact of Mometasone Furoate in Asthmatic Patients (Study P04879)(TERMINATED)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-11","conditions":"Asthma","enrollment":385},{"nctId":"NCT01566149","phase":"PHASE3","title":"Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-03","conditions":"Asthma","enrollment":49},{"nctId":"NCT01165424","phase":"PHASE3","title":"A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-04","conditions":"Rhinitis, Allergic, Perennial","enrollment":80},{"nctId":"NCT01471340","phase":"PHASE4","title":"A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-01-09","conditions":"Asthma","enrollment":11744},{"nctId":"NCT00359216","phase":"PHASE4","title":"The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Perennial Allergic Rhinitis, Obstructive Sleep Apnea, Sleep Disorder","enrollment":30},{"nctId":"NCT00521599","phase":"PHASE4","title":"A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05","conditions":"Asthma","enrollment":672},{"nctId":"NCT01258803","phase":"PHASE2","title":"A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-12","conditions":"Asthma","enrollment":92},{"nctId":"NCT00383721","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1196},{"nctId":"NCT00394355","phase":"PHASE4","title":"Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":566},{"nctId":"NCT00599027","phase":"PHASE3","title":"An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05","conditions":"Allergic Rhinitis, Asthma","enrollment":51},{"nctId":"NCT00732381","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08","conditions":"Allergic Rhinitis","enrollment":351},{"nctId":"NCT00733005","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-07","conditions":"Allergic Rhinitis","enrollment":324},{"nctId":"NCT01386125","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-06","conditions":"Nasal Polyps","enrollment":748},{"nctId":"NCT00423176","phase":"PHASE3","title":"The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"Sinusitis","enrollment":237},{"nctId":"NCT00442117","phase":"PHASE3","title":"A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06","conditions":"Asthma","enrollment":180}],"_emaApprovals":[],"_faersSignals":[{"count":2283,"reaction":"DYSPNOEA"},{"count":1885,"reaction":"HEADACHE"},{"count":1834,"reaction":"DRUG INEFFECTIVE"},{"count":1696,"reaction":"ASTHMA"},{"count":1676,"reaction":"FATIGUE"},{"count":1574,"reaction":"NAUSEA"},{"count":1523,"reaction":"COUGH"},{"count":1279,"reaction":"PRODUCT QUALITY ISSUE"},{"count":1266,"reaction":"DRUG DOSE OMISSION"},{"count":1247,"reaction":"WHEEZING"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL1161"},"formularyStatus":[],"_approvalHistory":[{"date":"20240607","type":"SUPPL","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"},{"date":"20230524","type":"SUPPL","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"},{"date":"20220920","type":"SUPPL","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"},{"date":"20220916","type":"SUPPL","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"},{"date":"20220317","type":"ORIG","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"},{"date":"20220920","type":"SUPPL","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"},{"date":"20220715","type":"SUPPL","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"},{"date":"20230309","type":"SUPPL","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"},{"date":"20220715","type":"SUPPL","sponsor":"PERRIGO PHARMA INTL","applicationNumber":"NDA215712"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":57,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Nasonex","genericName":"Nasonex","companyName":"University of Alberta","companyId":"university-of-alberta","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:51:01.476322+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}